Soluble Urokinase Plasminogen Activator Receptor as a Diagnostic and Prognostic Biomarker in Cardiac Disease

This review summarizes the published literature referring to the use and validity of the biomarker soluble urokinase plasminogen activator receptor (suPAR) when used for the assessment of patients with cardiac diseases. It is measured by enzyme-linked immunosorbent assay (ELISA) in plasma samples. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Velissaris, Dimitrios, Zareifopoulos, Nicholas, Koniari, Ioanna, Karamouzos, Vasilios, Bousis, Dimitris, Gerakaris, Andreas, Platanaki, Christina, Kounis, Nicholas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016523/
https://www.ncbi.nlm.nih.gov/pubmed/33854652
http://dx.doi.org/10.14740/jocmr4459

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8016523/
https://www.ncbi.nlm.nih.gov/pubmed/33854652
http://dx.doi.org/10.14740/jocmr4459

Ejemplares similares